Newsletters - OCT 2002

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

US Patent 6,436,991 dated August 20, 2002, granted to Sabinsa Corporation, covers the antioxidant and cancer chemopreventive roles of constituents of Gugulipid®, the Commiphora mukul extract composition from Sabinsa Corporation. This invention, titled "Compositions for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease", further unravels the multifaceted healthful benefits of this increasingly popular phytonutrient.

    HEADQUARTERS

  • Sabinsa Corporation
    20 Lake Drive
    East Windsor
    NJ 08520, USA

  • +1 732 777 1111
  • +1 732 777 1443
  • info@sabinsa.com

CERTIFICATES

Certificate Logos Certificate Logos Certificate Logos Certificate Logos

CONTACT US